What is the BioNTech SE - ADR (BNTX) price today?

The price of BioNTech SE - ADR (BNTX) today is $105.46. This value reflects the latest market rate available on Pluang. Check the asset page for additional details such as 24-hour change, market trends, and trading volume.

What are the trading hours of US Stocks?

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.

Do I get a dividend from investing in US Stocks?

Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.

What is the fee for each transaction?

Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Trade on Pluang

One platform for all markets

Download

Investment

Features

Fees Safety

Academy

Pluang+

Home/Explore/US Market Price/Stocks/BNTX

Buy & Sell BioNTech SE - ADR (BNTX) – BioNTech SE - ADR Price Today

Overview Financials Technicals Analysis Corp Action About

24H

YTD

Aura AI Summary

BioNTech (BNTX) trades at $105.46, down 0.09% on the day, with a bullish technical signal from moving averages but mixed oscillators. The company reported a net loss of $665.30 million in 2024, with revenue declining to $2.75 billion. Recent news highlights clinical progress in oncology, including positive Phase 2 results for an antibody-drug conjugate in HER2+ endometrial cancer (GlobeNewsWire, April 11, 2026).

Despite near-term losses, BioNTech's strong cash position of $16.78 billion and advancing oncology pipeline offer long-term potential. Risks include revenue volatility post-COVID and leadership transition as co-founders depart in 2026. Analyst consensus is bullish with an average price target of $131, implying 24% upside from current levels.

Read full analysis

Key Stats

Market Cap
$26.67B
Sector
Health
3M Drawdown
-29.71%
Enterprise Value
$9.60B
Dividend Yield
-
Typical Hold Time
52 days

$105.46

52W Low: $83.89

10 Mar 2026

52W High: $119.34

27 Jan 2026

BioNTech SE - ADR (BNTX) is currently valued at a market capitalization of $26.67B, with an enterprise value of $9.60B. Over the past 52 weeks, BioNTech SE - ADR has traded between a low of $83.89 and a high of $119.34, highlighting its annual price range. Over the past three months, BioNTech SE - ADR has recorded a drawdown of -29.71%, reflecting recent price volatility. On average, investors hold BioNTech SE - ADR for approximately 52 days, indicating typical investor behavior on the platform.

About BioNTech SE - ADR

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.

Technical Indicators

Overall Summary

Bearish (7)Neutral (8)Bullish (12)

News

Benzinga2 mon ago

BioNTech Stock Tumbles As Co-Founders Pivot To New MRNA Venture

Benzinga2 mon ago

Moderna's $950 Million Settlement Clears Legal Overhang, Stock Soars

Benzinga2 mon ago

Moderna, Coinbase, And Global Payments Are Among the Top 10 Large-Cap Gainers Last Week (Feb. 16-Feb. 20): Are the Others in Your Portfolio?

Benzinga2 mon ago

Moderna Faces Lawsuit From BioNTech Over Next-Generation COVID-19 Shot

Globe Newswire3 mon ago

Human Vaccines Market Size to Reach USD 62.45 Billion by 2033, Driven by Expanding Immunization Programs – SNS Insider

People also bought

US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

Market Cap
$26.67B
Sector
Health
3M Drawdown
-29.71%
Enterprise Value
$9.60B
Dividend Yield
-
Typical Hold Time
52 days

$105.46

52W Low: $83.89

10 Mar 2026

52W High: $119.34

27 Jan 2026

Let’s invest in this asset by signing up or download!

Buy & Sell BioNTech SE - ADR (BNTX) – BioNTech SE - ADR Price Today

Aura AI Summary

Key Stats

About BioNTech SE - ADR

People also bought

Key Stats

Invest

Features

Fees

Learn

Investment Clubs (Coming Soon)

Support

iOS App Store

Google Play Store